GlassScriptPhysician profile
Amy M Strocsher
NPI 1174714349
$2,097.48
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,042 · 2022: $1,035 · 2023: $20.26.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $20.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $20.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $571.14 | 2021-2022 | |
| Lilly USA, LLC | $188.02 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $174.32 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $148.80 | 2021-2022 | |
| Allergan, INC. | $121.13 | 2021 | |
| Pfizer INC. | $109.37 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $98.92 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $85.60 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $80.58 | 2021-2022 | |
| Abbott Laboratories | $71.55 | 2021-2022 | |
| Amgen INC. | $68.60 | 2021-2022 | |
| Novo Nordisk INC | $63.38 | 2021-2022 | |
| Sunovion Pharmaceuticals INC. | $63.09 | 2022 | |
| Novartis Pharmaceuticals Corporation | $44.48 | 2021 | |
| Boston Scientific Corporation | $41.65 | 2022-2023 | Watchman Flx |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.78 | 2022 | |
| Amarin Pharma, INC. | $31.72 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $31.11 | 2021 | |
| Jazz Pharmaceuticals INC. | $29.95 | 2021 | |
| Sanofi-Aventis U.S. LLC | $15.84 | 2022 | |
| Merck Sharp & Dohme LLC | $13.87 | 2022 | |
| Glaxosmithkline, LLC. | $12.58 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Strocsher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.